Ankara Bilkent City Hospital is a full-service city hospital located in Ankara, Turkey. Opened in 2019, it is the biggest in the country having a total of 3,704 hospital beds.

There are 3,704 beds in Ankara City Hospital.

During the past decade, Ankara City Hospital conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 4 clinical trials were completed, i.e. on average, 3.4% percent of trials that started reached the finish line to date. In the past 5 years, 110 clinical trials started and 3 clinical trials were completed. i.e. 2.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ankara City Hospital" #1 sponsor was "Ankara City Hospital Bilkent" with 57 trials, followed by "Hoffmann-La Roche" with 17 trials sponsored, "Janssen Research & Development, LLC" with 11 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Turkish League Against Rheumatism" with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara City Hospital" #1 collaborator was "Ankara City Hospital Bilkent" with 2 trials as a collaborator, "Klinar CRO" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Düzen Laboratories Group" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ankara City Hospital" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Covid19" (6 trials), "Postoperative Pain" (5 trials), "Cardiac Surgery" (4 trials) and "Arthritis, Psoriatic" (3 trials). Many other conditions were trialed in "Ankara City Hospital" in a lesser frequency.

Most popular intervention types in "Ankara City Hospital" are "Drug" (46 trials), "Other" (32 trials), "Procedure" (19 trials), "Device" (10 trials) and "Diagnostic Test" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Atezolizumab" (7 trials), "Carboplatin" (7 trials), "Paclitaxel" (5 trials) and "Pemetrexed" (5 trials). Other intervention names were less common.

The vast majority of trials in "Ankara City Hospital" are 98 trials for "All" genders, 14 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 59 active trials in "Ankara City Hospital". 6 are not yet recruiting, 36 are recruiting, 14 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 44 completed trials in Ankara City Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ankara City Hospital, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 29 trials that are defined as “Not Applicable".